NCT05949684: ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
- State
- Under way
- Phase
- Phase 3
- People
- 402 taking part
- Started
- 24 Oct 2023
- Primary completion
- 24 Mar 2028
- Arms
- Luspatercept
- Results
- None posted
- 18 Jul 2023: Trial registered
- 24 Oct 2023: Trial started